BetterInvesting™ Magazine Update on Paychex Inc. and Pfizer Inc.

March 28, 2024 – The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Paychex Inc. (NYSE: PAYX) as its “Stock to Study” and Pfizer Inc. (NYSE: PFE) as its “Undervalued Stock” in the June/July 2024 issue for investors’ informational and educational use.

“One of the top stock market stories of the week is the Reddit IPO. While IPOs are always headline-grabbing,” said Ken Zendel, chief executive officer of the National Association of Investors Inc., publisher of BetterInvesting, “the BetterInvesting educators remind investors to focus on the fundamentals, such as earnings, of individual companies, whether by using the Stock Selection Guide® or by doing their homework via other methods.”

Learn more about how to analyze companies and pick the best stocks at:
Check the June/July 2024 issue of BetterInvesting Magazine for more details about the latest stocks. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Paychex Inc. and Pfizer Inc. by viewing their fundamental data and applying judgments.

Committee members are Lauren Adams, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.  Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

Sample Our Resources Open House Get Your Resources